Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: Impact of maternal age and prenatal screening

European Journal of Human Genetics

Volumn 21, Issue 1, 2013, Pages 27-33

  Loane, Maria ^a   Morris, Joan K ^b   Addor, Marie Claude ^c   Arriola, Larraitz ^d   Budd, Judith ^e   Doray, Berenice ^f   Garne, Ester ^g   Gatt, Miriam ^h   Haeusler, Martin ⁱ   Khoshnood, Babak ^j   Klungsoyr Melve, Kari ^k   Latos Bielenska, Anna ^l   McDonnell, Bob ^m   Mullaney, Carmel ^m   O'Mahony, Mary ^m   Queißer Wahrendorf, Annette ⁿ   Rankin, Judith ^o   Rissmann, Anke ^p   Rounding, Catherine ^q   Salvador, Joaquin ^r   Tucker, David ^s   Wellesley, Diana ^t   Yevtushok, Lyubov ^u   Dolk, Helen ^a   more..

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Division of Medical Genetics   (Switzerland)

^d Laboratorio de Salud Pública de Gipuzkoa   (Spain)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g KOLDING HOSPITAL   (Denmark)

^h Department of Health Information and Research ^*  (Malta)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j INSERM   (France)

^k Medical Birth Registry of Norway   (Norway)

^l Polish Registry of Congenital Malformations   (Poland)

^m HEALTH SERVICE EXECUTIVE   (Ireland)

ⁿ JOHANNES GUTENBERG UNIVERSITY   (Germany)

^o NEWCASTLE UNIVERSITY   (United Kingdom)

^p UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^s PUBLIC HEALTH WALES   (United Kingdom)

^t UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^u OMNI Net for Children   (Ukraine)

more..

Author keywords

maternal age; prenatal screening; trends; trisomy 13; trisomy 18; trisomy 21

Indexed keywords

ADULT; ARTICLE; EUROPE; FEMALE; FETUS DEATH; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ABORTION, INDUCED; ADULT; AGE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; EUROPE; FEMALE; FETAL DEATH; HUMANS; LIVE BIRTH; MATERNAL AGE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; REGISTRIES; TRISOMY;

EID: 84871188596     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.94     Document Type: Article

References (29)

1. Breart G: Delayed childbearing. Eur J Obstet Gynecol Reprod Biol 1997; 75: 71-73.
2. EU statistics (EUROSTAT): maternal age at birth. http://epp.eurostat.ec. europa.eu/portal/page/portal/population/data/database (accessed 5 August 2010).
3. Smith DW: Recognizable patterns of human malformation, 3rd edn Philadelphia: WB Saunders Company, 1992.
4. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Goffinet F: A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2004. BJOG 2004; 111: 485-490.
5. Irving C, Basu A, Richmond S, Burn J, Wren C: Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet 2008; 16: 1336-1340.
6. Melve KK, Lie RT, Skjaerven R et al: Registration of Down syndrome in the Medical Birth Registry of Norway: validity and time trends. Acta Obstet Gynecol Scand 2008; 87: 824-830.
7. Cocchi G, Gualdi S, Bower C et al: International trends of Down syndrome 1993-2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res Part A Clin Mol Teratol 2010; 88: 474-479.
8. Boyd PA, DeVigan C, Khoshnood B, Loane M, Garne E, Dolk H. The EUROCAT working group. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for Neural Tube Defects and Down's syndrome. BJOG 2008; 115: 689-696.
9. Morris JK, Alberman E: Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register. BMJ 2010; 339: b3794.
10. Dolk H, Loane M, Garne E et al: Trends and geographic inequalities in the livebirth prevalence of Down Syndrome in Europe, 1980-1999. Revue Epidem Sante Publique 2005; 53: 2S87-2S95.
11. Pierannunzio D, Giorgi P: A decomposition model to evaluate evolution and factors of birth prevalence of Down syndrome in Europe. Genus 2005; 61: 85-118.
12. Boyd PA, Hauesler M, Barisic I, Loane M, Garne E, Dolk H: The EUROCAT Network: organisation and processes. Birth Defects Research Part A Clin Mol Teratol 2011; 91: S2-S15.
13. Greenlees R, Neville A, Addor MC et al: EUROCAT member registries: organization and activities. Birth Defects Research Part A Clin Mol Teratol 2011; 91: S51-S100.
14. EUROCAT member registries. http://www.eurocat-network.eu/fullmembers.
15. Loane M, Dolk H, Garne E, Greenlees R and a EUROCAT Working Group. EUROCAT Data quality indicators for population-based registers of congenital anomalies. Birth Defects Research Part A Clin Mol Teratol 2011; 91: S23-S30.
16. Baird PA, Sadovnick AD: Maternal age-specific rates for Down syndrome: changes over time. Am J Med Genet 1988; 29: 917-927.
17. Morris JK, Savva GM: The risk of fetal loss following a prenatal diagnosis of Trisomy 13 or Trisomy 18. Am J Med Genet 2008; 146A: 827-832.
18. Irving C, Richmond S, Wren C, Longster C, Embleton ND: Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med 2011; 24: 137-141.
19. EUROCAT prevalence tables. http://www.eurocat-network.eu/ accessprevalencedata/prevalencetables.
20. Bishop J, Huether CA, Torfs C, Lorey F, Deddens J: Epidemiologic study of Down Syndrome in a racially diverse California population, 1989-1991. Am J Epidemiol 1997; 145: 134-147.
21. Hook EB, Mutton DE, Idle R, Alberman E, Bobrow M: The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated. Am J Hum Genet 1995; 57: 875-881.
22. Bray I, Wright DE, Davies C, Hook EB: Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn 1998; 18: 9-20.
23. Hook EB: Chromosome abnormalities and spontaneous fetal death following amnio-centesis: further data and associations with maternal age. Am J Med Genet 1983; 35: 110-116.
24. Parker SE, Mai CT, Canfield MA et al: Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Research Part A Clin Mol Teratol 2010; 88: 1008-1016.
25. Savva GM, Walker K, Morris JK: The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome). Prenat Diagn 2010; 30: 57-64.
26. Vendola C, Canfield M, Daiger SP et al: Survival of Texas infants born with Trisomies 21, 18 and 13. Am J Med Genet Part A Clin Mol Teratol 2010; 152A: 360-366.
27. Crider KS, Olney RS, Cragan JD: Trisomies 13 and 18: Population prevalences, characteristics, and prenatal diagnosis, Metropolitan Atlanta, 1994-2003. Am J Med Genet A 2008; 146A: 820-826.
28. EUROCAT 2010. Special Report: Prenatal Screening Policies in Europe 2010, EUROCAT Central Registry, University of Ulster. http://www.eurocat-network.eu/ content/Special-Report-Prenatal-Screening-Policies.pdf.
29. Savva GM, Morris JK, Mutton DE, Alberman E: Maternal age-specific fetal loss in Down syndrome pregnancies. Prenat Diagn 2006; 26: 499-504.